Module Head – Clinical
Wellcome Trust Senior Research Fellow, Centre for Clinical Vaccinology & Tropical Medicine, Oxford University, UK
Honorary Consultant, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, UK
Principal Research Fellow, Menzies School of Health Research, Darwin, Australia
Infectious Diseases Consultant, Royal Darwin Hospital, Darwin, Australia
Professor Ric Price is a specialist in infectious diseases and microbiology, currently on the staff at the Royal Darwin Hospital, Australia, and an honorary consultant at the John Radcliffe Hospital, Oxford. The focus of his academic work is the investigation of multidrug resistant malaria and devising strategies for its containment. He coordinates a field site in Papua, Indonesia investigating the diagnosis and management of drug resistant P. falciparum and P. vivax. This work spans clinical studies, epidemiology, pathophysiology, in vitro studies and molecular biology. Ric also chairs the vivax working group of Asia-Pacific Malaria Elimination Network (APMEN).
Education
1999 MD, University of London, UK
1990 MA, Cambridge University, UK
1989 BA, MB, BChir, Cambridge University, UK
Professional Associations
Fellow, Royal College of Physicians, UK
Fellow, Royal College of Australian Physicians, Australia
Fellow, Royal College of Pathologists, UK
Representative Publications
Ratcliff A, Siswantoro H, Kenangalem E, Maritsela R, Wuwung M, Laihad F, Ebsworth EP, Anstey NM, Tjitra E, Price RN. Comparison of two fixed dosed artemisinin combinations for multi-drug resistant falciparum and vivax malaria in Papua, Indonesia. The Lancet, 369: 757-65, 2007.
Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN. Multidrug-resistant Plasmodium vivax malaria associated with severe and fatal malaria. PLoS Med 2008; 5(6): e128.
Price RN, Uhlemann AC, van Vugt M, Brockman A, Nair A, Hutagalung R, Nash D, Singhasivanon P, Anderson T, Krishna S, White NJ, Nosten F. Molecular and Pharmacological Determinants of the Therapeutic Response to Artemether-Lumefantrine in Multi-drug Resistant Falciparum Malaria. Clinical Infectious Diseases 2006; 42: 1570-7.
Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. The Lancet 2004; 364: 438-437.
Price RN, Nosten F, Luxemburger C, ter Kuile FO, Chongsuphajaisiddhi T and White NJ. Effects of artemisinin derivatives on malaria transmissibility. The Lancet 1996; 347: 1654-1658.
